Best of the Week
Most Popular
1. Gold Final Warning: Here Are the Stunning Implications of Plunging Gold Price - P_Radomski_CFA
2.Fed Balance Sheet QE4EVER - Stock Market Trend Forecast Analysis - Nadeem_Walayat
3.UK House Prices, Immigration, and Population Growth Mega Trend Forecast - Part1 - Nadeem_Walayat
4.Gold and Silver Precious Metals Pot Pourri - Rambus_Chartology
5.The Exponential Stocks Bull Market - Nadeem_Walayat
6.Yield Curve Inversion and the Stock Market 2019 - Nadeem_Walayat
7.America's 30 Blocks of Holes - James_Quinn
8.US Presidential Cycle and Stock Market Trend 2019 - Nadeem_Walayat
9.Dear Stocks Bull Market: Happy 10 Year Anniversary! - Troy_Bombardia
10.Britain's Demographic Time Bomb Has Gone Off! - Nadeem_Walayat
Last 7 days
BrExit Party EarthQuake Could Win it 150 MP's at Next UK General Election! - 18th May 19
Dow Stock Market Trend Forecast 2019 May Update - 18th May 19
US Economy to Die a Traditional Death… Inflation Is Going to Move Higher - 18th May 19
Trump’s Trade War Is Good for These 3 Dividend Stocks - 18th May 19
GDX Gold Mining Stocks Fundamentals Update - 17th May 19
Stock Markets Rally Hard – Is The Volatility Move Over? - 17th May 19
The Use of Technical Analysis for Forex Traders - 17th May 19
Brexit Party Set to Storm EU Parliament Elections - Seats Forecast - 17th May 19
Is the Trade War a Catalyst for Gold? - 17th May 19
This Is a Recession Indicator No One Is Talking About—and It’s Flashing Red - 17th May 19
War! Good or Bad for Stocks? - 17th May 19
How Many Seats Will Brexit Party Win - EU Parliament Elections Forecast 2019 - 16th May 19
It’s Not Technology but the Fed That Is Taking Away Jobs - 16th May 19
Learn to Protect your Forex Trading Capital - 16th May 19
Gold Ratio Charts Offer The Keys to the Bull Market - 16th May 19
Is Someone Secretly Smashing the Stock Market at Night? - 16th May 19
Crude Oil Price Fails At Critical Fibonacci Level - 15th May 19
Strong Stock Market Rally Expected - 15th May 19
US China Trade Impasse Threatens US Lithium, Rare Earth Imports - 15th May 19
Gold Mind Reader's Guide to the Global Markets Galaxy: 'Surreal' - 15th May 19
Trade Wars and Other Black Swan Threats to Your Investments - 15th May 19
Our Long-Anticipated Gold Momentum Rally Begins - 15th May 19
Defense Spending Is Recession Proof - Defense Dividend Stocks - 15th May 19
US China Trade Issues Will Drive Market Trends – PART II - 14th May 19
The Exter Inverted Pyramid of Global Liquidity Credit risk, Liquidity and Gold - 14th May 19
Can You Afford To Ignore These Two Flawless Gold Slide Indicators? - 14th May 19
As cryptocurrency wallets become more popular, will cryptocurrencies replace traditional payments? - 14th May 19
How US Debt Will Reach $40 Trillion by 2025 - 14th May 19
Dangers Beyond a Trade War with China - 14th May 19
eBook - Greatest Tool for Trading? - 14th May 19
Classic Pitfalls for Inexperienced Traders - 14th May 19
Stock Market S&P 500 Negative Expectations Again - 13th May 19
Why Rising Living Standard in China Offers Global Hope - 13th May 19
Stock Market Anticipated Correction Starts On Cue! - 13th May 19
How Chinese Trade Issues Will Drive Stock Market Trends - 13th May 19
Amazon SCAM Deliveries for Fake Verified Purchaser Reviews "Brushing" - 13th May 19
Stock Market US China Trade War Panic - Video - 13th May 19
US Stock Market Leading Macro Economic Indicators Update - 12th May 19
SAMSUNG - BC94.L - Investing in AI Machine Intelligence Stocks - 11th May 19
US Increases Trade Tariffs Against China – Stock Markets, Gold, and Silver - 11th May 19
Who Has More To Lose In A No Deal Brexit? - 11th May 19
Gold at $1,344 Will Start Real Fireworks on the Upside - 11th May 19
Make America’s Economy Great Again - 10th May 19
Big US Stocks’ 2019 Fundamentals - 10th May 19
Stock Market US China Trade War Panic! Trend Forecast May 2019 Update - 10th May 19
Stock Market Shake-Out Continues – Where Is The Bottom? - 10th May 19

Market Oracle FREE Newsletter

Category: BioTech

The analysis published under this category are as follows.

Companies

Thursday, April 07, 2016

IBB (Biotech ETF) Baby Bull Market / Companies / BioTech

By: Gary_Savage

Here we go again. Remember when I warned traders not to short the baby bull in miners and exhorted them to not lose their position because surprises would come to the upside? Needless to say, many ignored that advice and they cost themselves dearly.

Now we have a second baby bull just getting started in Biotech. It still has a long ways to go. Yet I’m seeing some traders making the same mistakes again.

Read full article... Read full article...

 


Companies

Thursday, March 10, 2016

Seven Small-Cap Biotech Stocks on the Upswing 2016 / Companies / BioTech

By: TLSReport

Biotech stocks—and the stock market in general—took a dive at the beginning of 2016, headed down on macroeconomic factors such as financial instability in China. The Life Sciences Report's 2016 Small-Cap Biotech Watchlist was not immune to that movement, heading into negative territory almost from the moment the selected companies were introduced. But as the market has shown signs of rebounding, so too has the Watchlist.

Read full article... Read full article...

 


Companies

Thursday, February 04, 2016

Look North for Value-Priced Growth in Healthcare Biotech Stocks / Companies / BioTech

By: TLSReport

Canada is a wellspring for natural resources and the industries built around them. But the country also encompasses healthcare-related businesses that are growing, generating cash flow and flourishing. Bruce Campbell of StoneCastle Investment Management has managed both U.S. and Canadian portfolios, and he knows both spheres. As a hedge fund and mutual fund manager concentrating on Canadian companies, he has made a specialty in acquisitions of cash-generating healthcare companies. In this interview with The Life Sciences Report, Campbell discusses seven small-cap growth names, all of which have reached share-price levels that do not reflect their capacity to grow. Some may offer rare opportunities to buy at risk-mitigated value prices.

Read full article... Read full article...

 


Companies

Sunday, January 24, 2016

Regenerative Medicine’s Fountain of Youth / Companies / BioTech

By: Richard_Mills

Aubrey de Grey a biomedical gerontologist, predicted that the first person to live to a thousand has already been born. According to de Grey the key may lie in the field of regenerative medicine.

The Webster dictionary defines biological regeneration as “the restoration or the growth by an organism of organ or tissue, that have been lost, removed or injured.”

Dr. William Haseltine CEO of Human Genome Sciences, believes thatregenerative medicine is about assisting the body to heal itself. Dr. Haseltine coined the term "regenerative medicine," to describe the expected medical revolution that, in his view, could lead to human immortality.

Read full article... Read full article...

 


Companies

Thursday, December 17, 2015

Panelists Select 19 Small-Cap Biotech Stocks for 2016 Investing Watchlist / Companies / BioTech

By: TLSReport

In advance of the Biotech Showcase 2016, The Life Sciences Report has once again solicited top analysts to provide the names of innovative biotech companies that investors should keep an eye on in the upcoming year.

Nineteen companies have made the cut for inclusion in the 2016 Small-Cap Biotech Watchlist, now in its fourth year. The therapies under development address diverse indications, such as rare diseases, ophthalmological conditions, leg cramps, kidney disease, infections caused by catheters, and a number of cancers, with a variety of products, including traditional biologics, cell therapies and vaccines.

Read full article... Read full article...

 


Companies

Sunday, December 06, 2015

Biotech Stocks Continue to Offer Huge Returns for Investors / Companies / BioTech

By: Investment_U

Rachel Gearhart writes: Earlier this year, we argued investors should snatch up biotech bargains while they were hot.

And, boy, were we right.

This week’s chart looks at the performance of the NYSE Arca Biotechnology Index (NYSE: BTK) and the S&P 500 since the beginning of the year.

Read full article... Read full article...

 


Companies

Wednesday, November 11, 2015

How to Engineer a Strong Portfolio with Medtech and Biotech / Companies / BioTech

By: TLSReport

Zacks Small-Cap Research analyst Anita Dushyanth is a bioengineer with an R&D background, which comes in handy as she researches up-and-coming companies in the medtech and biotech sectors. In this interview with The Life Sciences Report, Dushyanth focuses on four small- and micro-cap specialty pharma and device names with engineering tie-ins, and she expects all to produce exciting results for investors.

Read full article... Read full article...

 


Companies

Thursday, November 05, 2015

Regenerating Biotech Portfolios with Cell Therapies, Antibodies and Small Molecules / Companies / BioTech

By: TLSReport

Reni Benjamin of Raymond James has watched biotechnology move into a new era in which cells and genes can be manipulated to produce true disease-modifying results. In this interview with The Life Sciences Report, Benjamin outlines the groundbreaking work being done by a number of companies with the potential to return multiples on investment over the next two to three years.

Biotech Index One Year. Courtesy Google Finance

Read full article... Read full article...

 


Companies

Thursday, October 29, 2015

The Small-Cap Biotech Stocks Bull Market / Companies / BioTech

By: TLSReport

SeeThruEquity's Ajay Tandon and Jay Albany are riding the biotech bull by harnessing the huge upside potential of micro-cap companies working in multiple subsectors, particularly in the rapidly advancing cancer immunotherapy sector. In this interview with The Life Sciences Report, Tandon and Albany toss the names of several companies into the arena for investors' consideration.

The Life Sciences Report: Given the current healthcare market, how does the future look for small-cap biotechs versus large-cap companies?

Read full article... Read full article...

 


Companies

Thursday, October 08, 2015

Moving Stem Cell Research Forward: Bernie Siegel of the Genetics Policy Institute / Companies / BioTech

By: TLSReport

Regenerative medicine through stem cell technology is a source of hope for many suffering from ailments including Alzheimer's disease, diabetes, spinal cord injury and cancer. While new therapeutic options are continually in development, progress has, until recently, been hampered by political and medical ethics arguments. Because of patient advocacy, new technologies are now advancing, from development of an artificial pancreas to the hope of culturing intact human organs. In this interview with The Life Sciences Report, Bernie Siegel, founder and executive director of the Genetics Policy Institute, describes recent progress and developments in the regenerative medicine universe.

Read full article... Read full article...

 


Companies

Thursday, October 01, 2015

Advice for Biotech Investors: 'Hold Your Powder' 'til Winter / Companies / BioTech

By: TLSReport

While waiting for biotech stocks to correct, investors should be focused on performing due diligence, says Hartaj Singh of investment firm BTIG LLC. Growth in company valuations has outpaced sales for several years, but the coming weeks will see rapid fluctuations as the two begin to realign. In this interview, Singh shares his predictions for the rest of 2015 with The Life Sciences Report, and identifies several companies to hold for potentially big returns.

Read full article... Read full article...

 


Companies

Monday, September 28, 2015

The One Stocks Indicator to Watch as More Bubbles Burst / Companies / BioTech

By: ...

Michael E. Lewitt writes: One by one, the bubbles are bursting…

First it was the commodities bubble that blew up in mid-2014, which caused the collapse of energy and commodity stocks -they are now down between 40-80%.

It also caused the end of the corporate credit bubble in high yield bonds and bank loans over the second half of 2014 and into this year.

Read full article... Read full article...

 


Companies

Thursday, August 27, 2015

Novel Biotech Novel Technology Platforms with Dramatic Growth Potential / Companies / BioTech

By: TLSReport

In the past five years, development of new therapies has aimed for true disease modification and actual cures. Many novel ideas are now in the clinic, and have opened up fresh opportunities for dramatic industry growth, especially in the gene and cellular therapy realm. In this interview with The Life Sciences Report, David Nierengarten of Wedbush Securities brings a handful of select names to investors' attention, including a couple of companies with technologies that could revolutionize medicine.

The Life Sciences Report: You are a molecular and cell biologist, but you've been in the world of finance now for about a dozen years. What attracted you to finance?

Read full article... Read full article...

 


Companies

Sunday, August 23, 2015

A Perfect Buying Opportunity in Biotech Stocks / Companies / BioTech

By: Investment_U

Bob Creed writes: If you’ve held a position in the biotech sector over the last few years, it may have felt like you were on a roller coaster. Fortunately, this is one coaster that’s well worth the ride.

This week’s chart looks at the performance of the NYSE Biotech Index (NYSE: BTK) since July 2011. As you can see, biotech stocks have seen plenty of volatility. But any big drops were more than made up for by even bigger uptrends.

Read full article... Read full article...

 


Companies

Thursday, August 20, 2015

Two Tactics for Bigger Biotech Investing Profits / Companies / BioTech

By: ...

MoneyMorning.com Ernie Tremblay writes: Over the past six months, we've seen the Nasdaq Biotechnology Index, an indicator for the entire sector, take some wild swings up and down, often by as much as 10% from week to week.

That's in stark contrast to the previous half-year, when we experienced a relatively steady upward swell.

Read full article... Read full article...

 


Companies

Thursday, August 13, 2015

Harness Biotech Stock Volatility with an Options Strategy / Companies / BioTech

By: TLSReport

Volatility is the nature of the biotech beast, and it must be tamed or utilized to advantage. That's the philosophy of Eden Rahim, portfolio manager and option strategist at Theta Strategies Capital. Can you grow a portfolio if some of your more successful names are called away by option buyers before the stock goes into the stratosphere? The answer is yes, and in this interview with The Life Sciences Report, Rahim describes his technique and leaves readers with six names that he fully expects to reap very large gains.

The Life Sciences Report: You are CEO and cofounder of Theta Strategies Capital, and also the portfolio manager and innovator of the Next Edge Theta Yield Fund, which derives income from the options strategies you have developed over two decades. These strategies profit, in part, from the decline in pricing that occurs as options approach expiration. Could you describe that strategy?

Read full article... Read full article...

 


Companies

Friday, August 07, 2015

This Bioscience Company Has "Nearly Limitless" Income Potential / Companies / BioTech

By: ...

MoneyMorning.com Ernie Tremblay writes: Medical device companies can be profit-making machines – one manufacturer of magnetic resonance imaging (MRI) machines and other high-tech products is up more than 250% over the past 12 months, for instance.

Most of them make their living by staying on the leading edge of innovation, producing some of the coolest gadgets you can imagine.

And, even better, they can deliver some of the most impressive gains in the bioscience industry to their shareholders.

Read full article... Read full article...

 


Companies

Friday, July 24, 2015

Don’t Be Fooled by the “Quiet Season” for Biotech Stocks / Companies / BioTech

By: EWI

Marc Lichtenfeld writes: My favorite time to work is on weekend mornings before the rest of the house gets up.

I wake up, quietly go down the stairs and turn on the computer. While I’m waiting for it to boot up, I enjoy the peaceful scenery of the marsh outside my living room window. There are always amazing birds out there like sandhill cranes and egrets that are just a few feet from my window.

Read full article... Read full article...

 


Companies

Sunday, July 19, 2015

BSS Life Sciences Biotech Stock Analysis / Companies / BioTech

By: Richard_Mills

An endoscope is the medical device used - by direct insertion - to visualize suspicious masses in the hollow organs of the body such as the gastrointestinal tract, esophagus, lungs, urinary tract and uterus.

In 1805, Philip Bozzini used a rudimentary, light-guiding tube he created (a Lichtleiter - light guiding instrument) to view the urinary tract, pharynx, and rectum.

Read full article... Read full article...

 


Companies

Friday, July 03, 2015

The Biotech Market Is on Fire / Companies / BioTech

By: ...

MoneyMorning.com Spending on drugs here in the United States increased 13% last year to $374 billion – the single-biggest one-year jump in history. That’s a record-setting 4.3 billion prescriptions filled.

That means spending on drugs is rising at a rate that’s five times faster than the growth of the overall economy.

Read full article... Read full article...

 


Page << | 1 | 2 | 3 | 4 | 5 | >>